Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Feb / Diamonds Are a Diagnostician’s Best Friend
Infectious Disease Analytical science Biochemistry and molecular biology Molecular Pathology

Diamonds Are a Diagnostician’s Best Friend

A diagnostic sensor for rapid, cost-effective, and accurate detection of SARS-CoV-2

By Liv Gaskill 02/08/2022 Quick Read (pre 2022) 1 min read

Share

We are almost two years into the COVID-19 pandemic and, though both point-of-care and lab diagnostics have come a long way, there is always room for improvement. Recognizing this, researchers from the Massachusetts Information Technology and the University of Waterloo have developed a new approach to testing for SARS-CoV-2 – based on theoretical quantum effects (1).

The approach involves coating nanodiamonds that contain nitrogen vacancy centers (atomic-scale defects that are highly sensitive to tiny alterations) with a magnetically coupled material that bonds only with the RNA sequence of SARS-CoV-2. Presence of virus-specific RNA disrupts this magnetic connection and changes the fluorescence of the diamond, which is then detected by a sensor. In the paper, the authors state that the rapid method is “fast and promises to reach a sensitivity down to a few hundreds of RNA copies with false negative rate less than one percent.”

Using mathematical simulations, MIT researchers have shown that it would be possible to design a sensor, based on quantum physics, that could detect the SARS-CoV-2 virus. Credit: Courtesy of the researchers, edited by MIT News.

“The proposed approach is appealing both for its generality and its technological simplicity,” said David Glenn, senior research scientist at Quantum Diamond Technologies Inc., though he was not associated with the research (2). “The sensitive, all-optical detection technique described here requires minimal instrumentation compared to other methods that employ nitrogen vacancy centers.”

What’s next? The team now hopes to translate their mathematical simulations into a working device that can be used in the lab to confirm their predictions. “Even if complications arise in translating the theoretical analysis into a working device, there is such a large margin of lower false negatives predicted from this work that it will likely still have a strong advantage over standard PCR tests,” said senior author Paola Cappellaro (2). “And even if the accuracy were the same, this method would still have a major advantage in producing its results in a matter of minutes, rather than requiring several hours.”

Hero and Teaser image provided by Matthias Weinberger from flickr.com

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. C Li et al., Nano Lett, 22, 43 (2021). PMID: 34913700.
  2. David L. Chandler (2021). Available at: https://bit.ly/3IwL9qx.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Viral Frontier
Infectious Disease
The Viral Frontier

January 23, 2024

1 min read

The latest on the UK COVID-19 inquiry

What’s New in Infectious Disease? (December 2021)
Infectious Disease
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Infectious Disease
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

Pneumocystis Mysteries
Infectious Disease
Pneumocystis Mysteries

January 21, 2022

1 min read

What is the correct name for this pneumonia-causing pathogen?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.